- Previous Close
20.69 - Open
21.80 - Bid 22.01 x --
- Ask 22.02 x --
- Day's Range
21.25 - 22.75 - 52 Week Range
18.88 - 27.60 - Volume
138,943,822 - Avg. Volume
12,603,952 - Market Cap (intraday)
43.542B - Beta (5Y Monthly) --
- PE Ratio (TTM)
28.23 - EPS (TTM)
0.78 - Earnings Date Apr 26, 2025
- Forward Dividend & Yield 0.15 (0.72%)
- Ex-Dividend Date Jun 20, 2024
- 1y Target Est
--
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. Beijing Tiantan Biological Products Co., Ltd. was founded in 1966 and is headquartered in Beijing, China.
www.tiantanbio.comRecent News: 600161.SS
View MorePerformance Overview: 600161.SS
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600161.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600161.SS
View MoreValuation Measures
Market Cap
40.91B
Enterprise Value
38.28B
Trailing P/E
26.53
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.81
Price/Book (mrq)
3.67
Enterprise Value/Revenue
6.35
Enterprise Value/EBITDA
13.27
Financial Highlights
Profitability and Income Statement
Profit Margin
25.68%
Return on Assets (ttm)
10.48%
Return on Equity (ttm)
15.48%
Revenue (ttm)
6.03B
Net Income Avi to Common (ttm)
1.55B
Diluted EPS (ttm)
0.78
Balance Sheet and Cash Flow
Total Cash (mrq)
2.69B
Total Debt/Equity (mrq)
0.37%
Levered Free Cash Flow (ttm)
-1.3B